Tatva Chintan Pharma Chem Hits 52-Week High of Rs 1,880: What’s Driving the Stock Today
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Tatva Chintan Pharma Chem Share Price is in focus after the stock touched a fresh 52-week high of Rs 1,880.45 and then closed lower at Rs 1,768.25, down Rs 22.95 or 1.28% on 28 September 2026. The company’s market capitalisation stood at Rs 4,189.98 crore. This Tatva Chintan Pharma Chem Share Price update confirms a yearly high event, but the supplied data does not establish a company-specific catalyst. The move still makes Tatva Chintan Pharma Chem Share Price relevant for stock news tracking because it combines a new peak with a same-day pullback, which leaves investors comparing the day’s range, turnover of Rs 1.87 crore and the broader valuation setup. Univest tracks this event as a fresh 52-week-high stock market development rather than an all-time high.
The data also shows that the stock opened at Rs 1,809 and moved between Rs 1,763.90 and Rs 1,880.45 during the session. For readers following Tatva Chintan Pharma Chem Share Price Today, the key question is not only where the price closed, but how the day’s range compared with the 52-week peak and the company’s current market value. Univest highlights the event because Tatva Chintan Pharma Chem Share News now includes both the yearly high and a negative close, a combination that often draws attention in Indian stock market screens without implying any cause beyond the verified price action.
Tatva Chintan Pharma Chem Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,768.25 |
| Previous Close | Rs 1,791.2 |
| Today's Move | Rs -22.95 (-1.28%) |
| Open | Rs 1,809 |
| High | Rs 1,880.45 |
| Low | Rs 1,763.9 |
| Turnover | Rs 1.87 crore |
| Market Capitalisation | Rs 4,189.98 crore |
Tatva Chintan Pharma Chem Ltd. (TATVA) traded at Rs 1,768.25 versus the previous close of Rs 1,791.2, a fall of 1.28%. The stock opened at Rs 1,809, reached a high of Rs 1,880.45 and touched a low of Rs 1,763.9.
Tatva Chintan Pharma Chem Share Price Today showed a wide intraday range and ended below the previous close. The stock finished at Rs 1,768.25 versus the previous close of Rs 1,791.20, a decline of Rs 22.95. The session opened at Rs 1,809, briefly reached Rs 1,880.45, and then eased to a low of Rs 1,763.90 before the close. That high matches the fresh 52-week high, so the stock did print a yearly peak even though the final close was softer than the opening and prior close. Turnover of Rs 1.87 crore places the move in a clearly measurable trading context, and the price action confirms a new high without adding any company-specific reason. In Tatva Chintan Pharma Chem Share Price terms, the day was defined by a new peak, a broad range and a lower close. That sets up the next question for Tatva Chintan Pharma Chem Share Price analysis: how the current valuation and company financials compare with its sector backdrop.
Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,189.98 crore |
| P/E Ratio | 81.54x |
| P/B Ratio | 5.25x |
| ROE | 5.53% |
| ROCE | 7.17% |
| EPS | Rs 21.97 |
| Book Value Per Share | Rs 341.03 |
| Dividend Yield | 0.11% |
Tatva Chintan Pharma Chem Ltd. (TATVA) fundamental metrics show P/E 81.54x, P/B 5.25x, ROE 5.53%, ROCE 7.17%. These figures provide context only and are not a buy or sell signal.
Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4189.98 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 81.54x, P/B at 5.25x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 21.97, book value per share of Rs 341.03, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 26.23x, median ROE of 7.76%, median ROCE of 10%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Chemicals |
| Industry | Chemicals |
| Benchmark Scope | same industry |
| Company P/E Ratio | 81.54x |
| Benchmark Median P/E | 26.23x |
| Benchmark Average P/E | 50.81x |
| Benchmark P/E Range | 5.43x to 765.18x |
| Company P/B Ratio | 5.25x |
| Benchmark Median P/B | 1.97x |
| Company ROE | 5.53% |
| Benchmark Median ROE | 7.76% |
| Company ROCE | 7.17% |
| Benchmark Median ROCE | 10% |
| Company Market Capitalisation | Rs 4,189.98 crore |
| Benchmark Median Market Cap | Rs 445.71 crore |
Tatva Chintan Pharma Chem Ltd. (TATVA) is classified under sector: Chemicals and industry: Chemicals.
Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 81.54x, which is above the benchmark median of 26.23x, a difference of +210.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROE of 5.53%, which is below the benchmark median of 7.76%, a difference of -28.74%. Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 10%, a difference of -28.3%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Grauer & Weil (India) Ltd. | GRAUWEIL | 3,996.82 | 24.95 | 3.56 | 16.23 | 21.55 |
| GHCL Ltd. | GHCL | 3,868.57 | 8.19 | 1.09 | 13.46 | 18.12 |
| Epigral Ltd. | EPIGRAL | 4,574.06 | 16.88 | 1.97 | 16.09 | 15.65 |
| Gujarat Alkalies And Chemicals Ltd. | GUJALKALI | 4,632.03 | 69.81 | 0.88 | -0.04 | 1.4 |
| Vishnu Chemicals Ltd. | VISHNU | 4,706.01 | 31.44 | 4.24 | 14.26 | 16.38 |
Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 81.54x compared with the displayed peer median of 24.95x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 5.53% compares with a peer median of 14.26% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 16.38%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem Ltd. (TATVA) has a market capitalisation of Rs 4,189.98 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Tatva Chintan Pharma Chem
- Tatva Chintan Pharma Chem Share Price touched a fresh 52-week high of Rs 1,880.45 during the session.
- The stock closed at Rs 1,768.25, down 1.28% from the previous close of Rs 1,791.20.
- Market capitalisation stood at Rs 4,189.98 crore, which frames the current Tatva Chintan Pharma Chem Share Price update.
- P/E of 81.54 and P/B of 5.25 place the stock above the supplied chemicals benchmark medians.
- ROE of 5.53% and ROCE of 7.17% are below the benchmark medians in the same industry set.
About Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Ltd. operates in the chemicals sector and the chemicals industry. The supplied data classifies it within the same industry benchmark used in this article. In Univest’s Tatva Chintan Pharma Chem Share Price coverage, that classification matters because the stock is being compared with other listed chemicals names on valuation, return ratios and market capitalisation. The company profile data supplied here is limited to sector and industry classification, so this section stays strictly factual and avoids adding anything beyond the verified record.
Track Tatva Chintan Pharma Chem Share Price on Univest
Use Tatva Chintan Pharma Chem Ltd. (TATVA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Tatva Chintan Pharma Chem Share Price on Univest for live share price updates, financial ratios, shareholding pattern, 52-week levels, market capitalisation and company-specific stock analysis. Univest also presents Tatva Chintan Pharma Chem Share Price Today, Tatva Chintan Pharma Chem Stock News and broader market context in one place, making it easier to follow fresh 52-week-high moves and compare them with sector and peer data.
Tatva Chintan Pharma Chem Share Price remains a notable stock news item because the session delivered a fresh 52-week high, a lower close and a valuation profile that sits above the supplied chemical sector medians. For readers scanning Tatva Chintan Pharma Chem Share Price Live, the key verified facts are the price range, turnover, P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. Univest will keep tracking Tatva Chintan Pharma Chem Share Price as part of its 52 Week High Stocks coverage.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Tatva Chintan Pharma Chem Share Price in the news today?
Ans. Tatva Chintan Pharma Chem Share Price is in news because it touched a fresh 52-week high of Rs 1,880.45 before closing at Rs 1,768.25. The session also left a clear price range and turnover figure for analysis.
What is the latest Tatva Chintan Pharma Chem Share Price today?
Ans. The latest Tatva Chintan Pharma Chem Share Price in this update is Rs 1,768.25. It was below the previous close of Rs 1,791.20 after the stock moved between Rs 1,763.90 and Rs 1,880.45 during the session.
Did Tatva Chintan Pharma Chem hit a fresh 52-week high?
Ans. Yes. Tatva Chintan Pharma Chem Share Price touched Rs 1,880.45, which is the fresh 52-week high supplied in the data. The close was lower than that level, but the yearly peak was still printed in the session.
How is Tatva Chintan Pharma Chem valued on a P/E basis?
Ans. Tatva Chintan Pharma Chem Share Price carries a P/E ratio of 81.54. That is well above the supplied chemicals benchmark median of 26.23 and average of 50.81, placing valuation above the peer-set midpoint.
How do ROE and ROCE compare for Tatva Chintan Pharma Chem?
Ans. Tatva Chintan Pharma Chem Share Price is linked to ROE of 5.53% and ROCE of 7.17%. Both sit below the benchmark medians in the same industry set, so return ratios trail the sector reference point.
How does Tatva Chintan Pharma Chem compare with peers?
Ans. Tatva Chintan Pharma Chem Share Price is above several peers on P/E and P/B, while its ROE and ROCE are lower than companies such as Grauer & Weil and Vishnu Chemicals in the supplied peer list.
What is the market capitalisation of Tatva Chintan Pharma Chem?
Ans. Tatva Chintan Pharma Chem Share Price corresponds to a market capitalisation of Rs 4,189.98 crore. That figure places the company well above the industry market-cap median shown in the benchmark dataset.
